Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients
- 1 February 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59, S14-S18
- https://doi.org/10.1046/j.1523-1755.2001.59780014.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Indices of activity of the nitric oxide system in hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- l-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritisKidney International, 1999
- Endogenous Nitric Oxide Synthase InhibitorCirculation, 1999
- Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failureCardiovascular Research, 1998
- Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed RabbitsCirculation, 1997
- Determination of dimethylated arginines in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2BNitric Oxide, 1997
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failureNephrology Dialysis Transplantation, 1996
- Column chromatography of amino acids with fluorescence detectionJournal of Chromatography A, 1973